A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia
Clinical trial NCT03009487 · COMPLETED
Trial details
- NCT number
- NCT03009487
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2018-04-01
- Enrollment
- 265
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.